FGENFIBROGEN INC

Nasdaq fibrogen.com


$ 1.30 $ -0.11 (-7.8 %)    

Tuesday, 07-May-2024 12:44:20 EDT
QQQ $ 441.23 $ 1.71 (0.39 %)
DIA $ 388.80 $ -0.38 (-0.1 %)
SPY $ 517.69 $ 0.13 (0.03 %)
TLT $ 91.00 $ 0.15 (0.17 %)
GLD $ 214.10 $ -0.42 (-0.2 %)
$ 1.16
$ 1.41
$ 1.30 x 100
$ 1.31 x 100
$ 1.23 - $ 1.72
$ 0.33 - $ 19.47
1,207,401
na
114.82M
$ 1.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-07-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-01-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 03-26-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 fibrogen-q1-2024-gaap-eps-033-misses-031-estimate-sales-55902m-beat-36666m-estimate

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.31) by...

 why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

 fibrogen-unveils-early-data-from-prostate-cancer-candidate-analyst-advocates-further-exploration-in-the-landscape

FibroGen reveals Phase 1 results for FG-3246 for metastatic castration-resistant prostate cancer. Promising efficacy metrics an...

 fibrogen-reports-data-from-fortis-therapeutics-sponsored-phase-1-study-of-fg-3246

In the efficacy analysis, PSA reductions of ≥ 50% were observed in 36% of PSA evaluable patients. For RECIST evaluable patients...

 over-17m-bet-on-globalstar-check-out-these-4-penny-stocks-insiders-are-aggressively-buying

The Dow Jones index closed higher by around 47 points on Monday. When insiders purchase or sell shares, it indicates their conf...

 recap-fibrogen-q4-earnings
Recap: FibroGen Q4 Earnings
02/26/2024 21:25:18

 fibrogen-q4-2023-gaap-eps-057-misses-042-estimate-sales-2714m-miss-3890m-estimate

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.42) by...

 earnings-scheduled-for-february-26-2024

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on...

 fibrogens-earnings-outlook
FibroGen's Earnings Outlook
02/23/2024 18:01:39

 top-4-health-care-stocks-that-may-crash-this-quarter

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION